This nine minute video follows Dr. Michael Weiner, M.D., ADNI Principal Investigator and Professor of Medicine, Radiology, Psychiatry and Neurology at the University of California, San Francisco as he enrolls as a subject in the Alzheimer’s Disease Neuroimaging Initiative (ADNI)  clinical study. Watch the video here >>
 
As many as 5.3 million Americans are currently living with Alzheimer's disease. Today there is no cure, no disease-modifying treatment, and no way to prevent the disease. For years, scientists and clinicians around the world had been laboring to find breakthroughs that would aid in the diagnosis and treatment of Alzheimer’s disease—but with only limited success. ADNI is advancing the field in its understanding of the causes and progression of this debilitating disease.
 
Launched in 2004, ADNI has become a model of how public-private partnerships can lead to otherwise unattainable progress in biomedical research.  ADNI tracks more than 1000 subjects enrolled at 59 different clinical sites in the U.S. and Canada to study brain structure, function and biomarkers.
 
The Foundation for the NIH has been and continues to serve as an integral partner in this initiative. The Foundation raised more than $27 million in private-sector funding for the first phase of ADNI and has raised an additional $22 million to date for ADNI 2. But more importantly, the FNIH coordinates the partnerships and provides an independent, open and pre-competitive forum for all partners to collaborate, share information, receive project updates, and offer scientific and private-sector perspectives and expertise on ADNI and on the field of Alzheimer’s research. Funded by the National Institute on Aging (NIA), along with contributions that FNIH has secured from companies and nonprofit organizations, ADNI tracks subjects enrolled at different clinical sites in the U.S. and Canada to study brain structure, function and biomarkers. Over its initial six years, ADNI has succeeded as a groundbreaking collaboration, pooling the resources of government-, private- and nonprofit-sector stakeholders to create the largest partnership on brain research to date.
 
To learn more about ADNI and how you can support Alzheimer’s research please visit >>